The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2
Open accessAbstract
OBJECTIVE: To analyze gastrointestinal (GI) manifestations, their progression over time, and medications being used to treat GI symptoms in a large cohort of patients with myotonic dystrophy types 1 (DM1) and 2 (DM2). METHODS: We analyzed patient-reported data and medical records in a national registry cohort at baseline and 5 years. RESULTS: At baseline, the majority of patients reported trouble swallowing in DM1 (55%; n = 499 of 913) and constipation in DM2 (53%; n = 96 of 180). Cholecystectomy occurred in 16.5% of patients with DM1 and 12.8% of patients with DM2, on average before 45 years of age. The use of medications indicated for gastroesophageal reflux disease was reported by 22.5% of DM1 and 18.9% of patients with DM2. Greater risk of a GI manifestation was associated with higher body mass index and longer disease duration in DM1 and female sex in DM2. At the 5-year follow-up, the most common new manifestations were trouble swallowing in patients with DM1 and constipation in patients with DM2. CONCLUSIONS: GI manifestations were common in both DM1 and DM2, with a relatively high frequency of gallbladder removal in DM1 and DM2 occurring at a younger age compared to normative data in the literature. Studies are needed to determine the pathomechanism of how sex, weight gain, and duration of disease contribute to GI manifestations and how these manifestations affect quality of life and clinical care for patients with DM1 and DM2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gastrointestinal manifestations are common in myotonic dystrophy types 1 and 2, with high reported frequencies of constipation, diarrhea, abdominal pain, and dysphagia (Hilbert et al., 2017).”
From Autonomic nervous system and gastrointestinal manifestations with an emphasis on gastric dysfunction (2026) · cites this paper as Hilbert et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
El‐Serag, H. B., Sweet, S., Winchester, C., & Dent, J. (2013) · Gut · doi:10.1136/gutjnl-2012-304269 · Cited by 1,934
Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the Gene
Mahadevan, M. S., Tsilfidis, C., Sabourin, L. A., Shutler, G., Amemiya, C. T., Jansen, G., Neville, C., Narang, M. A., Barceló, J. M., O'Hoy, K., et al. (1992) · Science · doi:10.1126/science.1546325 · Cited by 1,656
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,453
Self-citationMyotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9
Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kreß, W., Naylor, S. L., Day, J., & Ranum, L. P. W. (2001) · Science · doi:10.1126/science.1062125 · Cited by 1,254
Self-citationThe Burden of Gastrointestinal and Liver Diseases, 2006
Shaheen, N. J., Hansen, R. A., Morgan, D. R., Gangarosa, L. M., Ringel, Y., Thiny, M. T., Russo, M. W., & Sandler, R. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00723.x · Cited by 694
Mitochondria: A central target for sex differences in pathologies
Ventura-Clapier, R., Moulin, M., Piquereau, J., Lemaire, C., Mericskay, M., Veksler, V., & Garnier, A. (2017) · Clinical Science · doi:10.1042/cs20160485 · Cited by 371
Genetic mapping of a second myotonic dystrophy locus
Ranum, L. P. W., Rasmussen, P. F., Benzow, K. A., Koob, M. D., & Day, J. (1998) · Nature Genetics · doi:10.1038/570 · Cited by 263
Self-citationCurrent Trends in the Management of Gastroesophageal Reflux Disease
Sandhu, D. S., & Fass, R. (2017) · Gut and Liver · doi:10.5009/gnl16615 · Cited by 218
Adverse Effects Associated With Proton Pump Inhibitors
Schoenfeld, A. J., & Grady, D. G. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7927 · Cited by 214
A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy
Zacks, S., Sandler, R. S., Rutledge, R. R., & Brown, R. S. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05466.x · Cited by 199
Dogan, C., Antonio, M. D., Hamroun, D., Varet, H., Fabbro, M., Rougier, F., Amarof, K., Arné‐Bes, M., Bédat‐Millet, A., Béhin, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148264 · Cited by 160
Gastrointestinal manifestations in myotonic muscular dystrophy
Bellini, M. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i12.1821 · Cited by 123
Myotonic dystrophy: approach to therapy
Thornton, C. A., Wang, E. T., & Carrell, E. M. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.03.007 · Cited by 97
Self-citationMyotonic dystrophy: present management, future therapy
(2004) · doi:10.1093/oso/9780198527824.001.0001 · Cited by 97
Gastrointestinal Symptoms in Myotonic Dystrophy
Rönnblom, A., Forsberg, H., & Danielsson, A. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609009145 · Cited by 86
Smooth muscle involvement in myotonic dystrophy
Harvey, J. C., Sherbourne, D. H., & Siegel, C. I. (1965) · The American Journal of Medicine · doi:10.1016/0002-9343(65)90247-0 · Cited by 82
Gastrointestinal involvement is frequent in Myotonic Dystrophy type 2.
Tieleman, A., van Vliet, J., Jansen, J. J., van der Kooi, A., Borm, G., & van Engelen, B. V. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.05.010 · Cited by 63
Hilbert, J. E., Kissel, J. T., Luebbe, E. A., Martens, W. B., McDermott, M., Sanders, D. B., Tawil, R., Thornton, C. A., & Moxley, R. T. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.11.016 · Cited by 61
Self-citationCancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation
Fernández‐Torrón, R., García-Puga, M., Emparanza, J. I., Maneiro, M., Cobo, A.-M., Poza, J.-J., Espinal, J. B., Zulaica, M., Ruiz, I., Martorell, L., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003124 · Cited by 58
Gastric and esophageal emptying in dystrophia myotonica
Horowitz, M., Maddox, A. F., Maddern, G. J., Wishart, J. M., Collins, P., & Shearman, D. J. C. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90003-5 · Cited by 56
Interventions for dysphagia in long-term, progressive muscle disease
Jones, K. L., Pitceathly, R. D. S., Rose, M. R., McGowan, S. L., Hill, M. E., Badrising, U. A., & Hughes, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004303.pub4 · Cited by 53
Heatwole, C. R., Eichinger, K. J., Friedman, D. I., Hilbert, J. E., Jackson, C. E., Logigian, E. L., Martens, W. B., McDermott, M., Pandya, S. K., Quinn, C. M., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.227 · Cited by 49
Self-citationConsensus on cerebral involvement in myotonic dystrophy
Bugiardini, E., & Meola, G. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.01.013 · Cited by 46
Correlates of tumor development in patients with myotonic dystrophy
Das, M., Moxley, R. T., Hilbert, J. E., Martens, W. B., Letren, L., Greene, M. H., & Gadalla, S. M. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6476-8 · Cited by 45
Self-citationPharyngo-Esophageal Motility Disturbances in Patients with Myotonic Dystrophy
Mearin, F. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655299750025336 · Cited by 43
Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable
Tarnopolsky, M. A., Pearce, E., Matteliano, A., James, C., & Armstrong, D. (2010) · Muscle & Nerve · doi:10.1002/mus.21787 · Cited by 40
Smooth muscle involvement in primary muscle disease. I. Myotonic dystrophy.
Pruzanski, W., & Ag, H. (1967) · PubMed · Cited by 33
Gastric emptying in myotonic dystrophic patients
Bellini, M., Alduini, P., Costa, F., Tosetti, C., Pasquali, L., Pucciani, F., Tornar, A., Mammini, C., Siciliano, G., Maltinti, G., et al. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80106-2 · Cited by 31
Oropharyngeal Dysphagia in Myotonic Dystrophy Type 1: A Systematic Review
Pilz, W., Baijens, L. W. J., & Kremer, B. (2014) · Dysphagia · doi:10.1007/s00455-013-9510-9 · Cited by 28
Liker, H. R., Ducrotte, P. R., & Malfertheiner, P. (2009) · Digestive Diseases · doi:10.1159/000210106 · Cited by 22
Cardani, R., Mancinelli, E., Saino, G., Bonavina, L., & Meola, G. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.06.366 · Cited by 22
Marcon, M., Briani, C., Ermani, M., Menegazzo, E., Iurilli, V., Feltrin, G., Novelli, G., Gennarelli, M., & Angelini, C. I. (1998) · Neurological Sciences · doi:10.1007/bf02427560 · Cited by 21
Cholelithiasis and Associated Complications of Myotonia Dystrophica
Schwindt, W. D., Bernhardt, L. C., & Peters, H. A. (1969) · Postgraduate Medicine · doi:10.1080/00325481.1969.11697335 · Cited by 15
Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy
Fitzgerald, B. P., Conn, K. M., Smith, J., Walker, A., Parkhill, A. L., Hilbert, J. E., Luebbe, E. A., & Moxley, R. T. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8300-3 · Cited by 9
Self-citationTanaka, Y., Kato, T., Nishida, H., Yamada, M., Koumura, A., Sakurai, T., Hayashi, Y., Kimura, A., Hozumi, I., Araki, H., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6842-1 · Cited by 9
Cisapride improves gallbladder kinetics in patients affected with myotonic muscular dystrophy.
Marchi, S., Polloni, A., Bellini, M., Orsitto, E., Costa, F., Spataro, M., Rossi, B., Siciliano, G., Masi, M. C., & Tumino, E. (1993) · PubMed · Cited by 5
Encoprésie révélatrice d’une dystrophie myotonique de Steinert : à propos de 2 observations
Avez‐Couturier, J., Michaud, L., Cuisset, J., Lamblin, M., Dolhem, P., Turck, D., Vallée, L., & Gottrand, F. (2009) · Archives de Pédiatrie · doi:10.1016/j.arcped.2009.02.018 · Cited by 3
Operable Heart Disease in the Newborn Period
Fyler, D. C., Nadas, A. S., & Bernhard, W. F. (1969) · Postgraduate Medicine · doi:10.1080/00325481.1969.11697235 · Cited by 2
Cited by
Sorted by citations
Gastrointestinal motility disorders in neurologic disease
Camilleri, M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143771 · Cited by 211
van den Bersselaar, L. R., Heytens, L., da Silva, H. C. A., Reimann, J., Tasca, G. A., Díaz‐Cambronero, Ó., Løkken, N., Hellblom, A., Hopkins, P. M., Rueffert, H., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15526 · Cited by 70
Consensus-based care recommendations for adults with myotonic dystrophy type 2
Schoser, B. G. H., Montagnese, F., Bassez, G., Fossati, B., Gámez, J., Heatwole, C. R., Hilbert, J. E., Kornblum, C., Kostera‐Pruszczyk, A., Krahe, R., et al. (2019) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000645 · Cited by 67
Self-citationAssessing the influence of age and gender on the phenotype of myotonic dystrophy type 2
Montagnese, F., Mondello, S., Wenninger, S., Kreß, W., & Schoser, B. G. H. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8653-2 · Cited by 57
Myotonic Dystrophies: Targeting Therapies for Multisystem Disease
LoRusso, S. J., Weiner, B., & Arnold, W. D. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-00679-z · Cited by 50
Metadata
- Authors
- Hilbert, J. E., Barohn, R. J., Clemens, P. R., Luebbe, E. A., Martens, W. B., McDermott, M. P., Parkhill, A. L., Tawil, R., Thornton, C. A., Moxley, R. T., National Registry Scientific Advisory Committee/Investigators, Ashizawa, T., Barohn, R. J., Clemens, P. R., Conneally, P. M., Day, J. W., Figlewicz, D. A., Jackson, J. M., Kissel, J. T., Lord, S., Mathews, K. D., Sanders, D. B., & Tapscott, S. J.
- Affiliations
- University of Pittsburgh (US)
- ORCID
- Venue
- Neurology
- Published
- 2017-09-26
- Volume
- 89
- Issue
- 13
- Pages
- 1348-1354
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC5649763
- OpenAlex
- W2753249033
- Cited by
- 70
- References
- 39
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 9 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 7 · 2019: 10 · 2018: 7 · 2017: 1
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Fisher Digital Publications (St. John Fisher College) (submittedVersion)
- Funders
- National Institutes of Health (5u54ns048843-12)
- Medical Center, University of Rochester
- National Institute of Neurological Disorders and Stroke (U54‐NS048843)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- myotonic dystrophy type 1, myotonic dystrophy type 2, gastrointestinal manifestations, dysphagia, constipation, cholecystectomy, gastroesophageal reflux disease, body mass index, disease duration, sex differences, disease progression
- MeSH terms
- Age Factors, Cholecystectomy, Female, Follow-Up Studies, Gastrointestinal Diseases, Humans, Male, Middle Aged, Myotonic Dystrophy, Registries, Risk Factors, Sex Factors, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
